Premium
Feasibility of Shortened Methacholine Challenge in Preschool Children
Author(s) -
Kivastik J.,
Gibson A.M.,
Primhak R.A.
Publication year - 2006
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.20341
Subject(s) - medicine , methacholine , pediatrics , intensive care medicine , respiratory disease , lung
The aim of our study was to assess the feasibility and safety of a recently suggested tripling‐dose methacholine (Mch) challenge in preschool children. Fifty‐seven children aged 3–6 years were studied. Mch challenge was carried out using a tidal breathing method, with concentrations of 0.22, 0.66, 2.0, 6.0, and 18.0 mg/ml, at 5‐min intervals, given by a Pari Turbo Boy compressor and Pari LC Plus nebulizer, for 1 min only. Oxygen saturation (SaO 2 ) was monitored during the challenge. The challenge was terminated if there was wheeze, SaO 2 below 91%, or persistent cough. This final Mch dose was considered the provocative concentration inducing audible wheeze (PCW). Nine healthy children, 17 with cough and 25 with wheeze, completed the study. Mean output from nebulizers (SD) in these 51 children was 0.30 (0.05) ml/min. Geometric means for PCW in these groups were 2.88, 2.58, and 1.28 mg/ml Mch, respectively. The wheezing children were significantly more hyperresponsive than the coughing children ( P < 0.05). A tripling‐dose Mch protocol is safe and practicable in children over 3 years of age. A further reduction in nebulized dose may be needed for a more discriminatory test. © 2005 Wiley‐Liss, Inc.